Down-regulation of the chemokine receptor CCR5 by activation of chemotactic formyl peptide receptor in human monocytes

Blood

Volumn 96, Issue 8, 2000, Pages 2887-2894

  Shen, W ^a   Li, B ^a   Wetzel, M A ^a   Rogers, T J ^a   Henderson, E E ^a   Su, S B ^a   Gong, W ^a   Le, Y ^a   Sargeant, R ^a   Dimitrov, D S ^a   Oppenheim, J J ^a   Wang, J M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FORMYLPEPTIDE; PROTEIN KINASE C; VIRUS RECEPTOR;

ARTICLE; CALCIUM MOBILIZATION; CHEMOTAXIS; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONOCYTE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

EID: 0034667536     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.8.2887.h8002887_2887_2894     Document Type: Article

References (35)

1. Chemokine receptors and HIV-1: The fusion of two major research fields
2. HIV and membrane receptors
3. HIV entry and tropism: The chemokine receptor connection
4. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure
5. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene: Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, Alive Study
6. Identification of RANTES, MIP-1α, MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells
7. Interaction of chemokine receptor CCR5 with its ligands: Multiple domains for HIV-1 gp120 binding and single domain for chemokine binding
8. Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist
9. HIV blocked by chemokine antagonist
10. Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication
11. The molecular biology of leukocyte chemoattractant receptors
12. The N-formyl peptide chemotactic receptors
13. The N-formyl peptide receptor: A model for the study of chemoattractant receptor structure and function
14. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation
15. Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus
16. Chemokine-induced phosphorylation of chemokine receptor 5 (CCR5)
17. Molecular mechanism of desensitization of the chemokine receptor CCR-5: Receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor
18. Similarities and differences in RANTES- and (AOP)-RANTES-triggered signals: Implications for chemotaxis
19. Chemoattractant receptor cross-desensitization
20. Mechanisms of inflammation and leukocyte activation
21. Cross-desensitization of receptors for peptide chemoattractants: Characterization of a new form of leukocyte regulation
22. T20/DP178, an ectodomain peptide of HIV-1 gp41, is a potent activator of human phagocyte N-formal peptide receptor
23. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
24. HIV-1 membrane fusion mechanism: Structural studies of the interactions between biologically-active peptides from gp41
25. A synthetic pepride from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion
26. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection
27. A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: Implication for viral fusion
28. N-formylmethionyl peptides as chemoattractants for leucocytes
29. Formyl peptide chemoattractants: A model of the receptor on rabbit neutrophils
30. N-terminus urea-substituted chemotactic peptides: New potent agonists and antagonists toward the neutrophil fMLF receptor
31. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils
32. Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor
33. Chemotactic peptide N-formyl-metleu-phe activation of p38 mitogen-activated protein kinase (MAPK) and MAPK-activated protein kinase-2 in human neutrophils
34. The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains
35. Intederence with the signaling capacity of CC chemokine receptor 5 can compromise its role as an HIV-1 entry coreceptor in T lymphocytes